An Evolutionary Framework for Association Testing in Resequencing Studies by King, C. Ryan et al.
An Evolutionary Framework for Association Testing in
Resequencing Studies
C. Ryan King
1*, Paul J. Rathouz
1,2, Dan L. Nicolae
3
1Department of Health Studies, University of Chicago, Chicago, Illinois, United States of America, 2Department of Biostatistics and Medical Informatics, University of
Wisconsin-Madison, Madison, Wisconsin, United States of America, 3Departments of Medicine, Statistics, and Human Genetics, University of Chicago, Chicago, Illinois,
United States of America
Abstract
Sequencing technologies are becoming cheap enough to apply to large numbers of study participants and promise to
provide new insights into human phenotypes by bringing to light rare and previously unknown genetic variants. We
develop a new framework for the analysis of sequence data that incorporates all of the major features of previously
proposed approaches, including those focused on allele counts and allele burden, but is both more general and more
powerful. We harness population genetic theory to provide prior information on effect sizes and to create a pooling strategy
for information from rare variants. Our method, EMMPAT (Evolutionary Mixed Model for Pooled Association Testing),
generates a single test per gene (substantially reducing multiple testing concerns), facilitates graphical summaries, and
improves the interpretation of results by allowing calculation of attributable variance. Simulations show that, relative to
previously used approaches, our method increases the power to detect genes that affect phenotype when natural selection
has kept alleles with large effect sizes rare. We demonstrate our approach on a population-based re-sequencing study of
association between serum triglycerides and variation in ANGPTL4.
Citation: King CR, Rathouz PJ, Nicolae DL (2010) An Evolutionary Framework for Association Testing in Resequencing Studies. PLoS Genet 6(11): e1001202.
doi:10.1371/journal.pgen.1001202
Editor: Jonathan Marchini, University of Oxford, United Kingdom
Received May 12, 2010; Accepted October 7, 2010; Published November 11, 2010
Copyright:  2010 King et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: CRK was supported by Medical Scientist National Research Service Award T 32 GM07281 and 1F30HL103105-01. PJR was supported by R21 MH086099-
01. DLN was supported in part by 1RC1HL099619-01 and 1RC2HL101651-01. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: cking@health.bsd.uchicago.edu
Introduction
Over the past 20 years, positional cloning guided by linkage
analysis and genome wide association studies (GWAS) have
identified many loci relevant to human disease and other
quantitative phenotypes such as height, body mass index, and
serum lipid composition. However, in most cases the total amount
of phenotypic variance explained is small compared to the
heritability observed in twin or adoption studies [1]. Some authors
note the possibility that low-frequency genetic variation, which is
not measured on standard single nucleotide polymorphism (SNP)
arrays, may contribute to this missing heritability [2–7]. The rapidly
decreasing cost of obtaining DNA sequence has prompted several
groups to test this hypothesis by sequencing candidate genes in
participants of cohort or case-control studies hoping to discover
either 1) rare or previously unknown SNPs with large detectable
effect sizes, or 2) a correlation between overall number of rare SNPs
and phenotype [8–15]. This research is rapidly approaching a new
phase as investigators use next-generation sequencing technology to
measure all variation in the exome and wider genome [16,17].
Several authors have shown that rare variation is particularly
relevant in the case that natural selection has acted to keep variants
with large effects rare, and that without action by purifying selection
rare variants have effect sizes comparable to common ones [2,3,6].
There are three signatures of association in a resequencing study
which we want to use to assess candidate genes. Some SNPs could
have effect sizes large enough that they have individually
noticeable impact on phenotype; this is the information underlying
regression procedures, like those put forward by Hoggart et al [18]
and Kwee et al [19]. This approach is very similar to current tag-
SNP based procedures and not designed thinking of resequencing
data, since the effects of rare SNPs will not be easy to discern.
Depending on the role natural selection has played in the history
of the phenotype, two other signatures of association may exist.
Second, rare SNPs may tend to have effect sizes in the same
direction (e.g. inducing risk), so a measure of overall rare-variant
burden could correlate to phenotype; this is the information
exploited in allele-count [20] and rare-variant-burden [21] type
methods. That signature may be present if either selection has
favored the phenotype (or a correlate) in a particular direction, or
if purifying selection has been weak and derived alleles tend to be
deleterious to the phenotype. Finally, rare SNPs could tend to
have effect sizes which are larger than common ones. This could
be the case if selection has tended to stabilize the phenotype. The
method of Kwee et al [19] can allow for that possibility, but does
not contain guidance on what the structure of the frequency -
effect size relationship should be.
We present a method capable of detecting all three signatures of
association. Our method generalizes allele count and rare-variant-
burden methods by explicitly constructing a model relating disease
impact, selective pressure, and SNP frequency in a candidate gene.
By doing so, we will be able to provide intuitive interpretations to
detected associations, allowing investigators to answer additional
questions with their data. Our approach will yield substantially
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bias or sacrificing much efficiency when our assumptions are not
met.
We propose to estimate the evolutionary fitness burden of each
SNP using its observed frequency and population genetic
parameters inferred by other authors. That estimate of fitness
burden will act as prior information on the variant effect, acting
like a burden function [21]. The same estimate will structure the
variability of SNP-phenotype correlations, replacing arbitrary
weights [19], and provide robust estimates even if there is no
relationship between fitness and effect magnitude. We recognize
that for a quantitative trait measured in a prospective cohort, a
well-justified approximation of the full model can be fit using a fast
and general statistical technique, mixed linear models, and provide
software routines to estimate parameters and conduct hypothesis
tests. We have named the approach EMMPAT (Evolutionary
Mixed Model for Pooled Assocation Testing)
In what follows, we will briefly introduce the population genetics
ideas which underly our approach. Next, we construct our
statistical model and discuss estimation and testing within it.
Finally, we illustrate the method both in simulation studies and on
a real candidate gene resequencing study examining serum
triglyceride levels in a multi-ethnic prospective community-based
sample [8,12].
Relating SNP Frequency, Fitness, and Disease Effect
Several authors have reviewed the potential contribution of low
frequency alleles to variation in phenotypes [2–7]. Absent a
change in the properties of new mutations during recent history,
which we find implausible, systematic differences between SNPs of
varying frequencies must be mediated by natural selection. Since
the early 20th century, much work has explicated the evolutionary
dynamics of quantitative traits, reviewed by Barton and Johnson
[22,23]. Below we will posit a model of pleiotropic selection
whereby the trait under study or a trait with a correlated genetic
basis is under purifying selection. More detailed connection and
contrast to the existing work on the genetic basis of quantitative
traits is found in Text S1.
In Figure 1, we illustrate direct and apparent selection scenarios
which give rise to a correlation between fitness effects and
phenotype effects. In Figure 1A, the phenotype itself is under
selective pressure; for example, disease leading to propensity to
childhood mortality. Figure 1B shows apparent selection by
pleiotropy; variants which disrupt an unconstrained role of a gene
also tend to disrupt another role which is under selection; for
example, variation which increases Alzheimer’s Disease risk after
reproductive age may relate to other brain function which is
relevant for individuals still reproducing.
Hartl and Clark [24] carefully constructs and interprets the
concept of fitness-effects in classical population genetics. Briefly, in an
idealized population, the relative reproductive advantage of an
individual is the product of the fitness effects of each variant that
person carries, an additive approximation with no dominance or
epistasis. We parameterize the problem in terms of the log of
multiplicative fitness effects. That is, the fitness of the ith person is
given by Si~exp
P
j sjGij
  
where the fitness effect of the jth variant
is denoted sj and Gij i st h eu n p h a s e dg e n o t y p ea tt h a tl o c u s .T h e
fitness effect of a new mutation sj determines several of its properties,
such as average sojourn time before either going extinct or fixing at
100% prevalence and average frequency when sampled at a point in
time [24].
Rather than assume that all variants in the region have the same
sj, we assume that the sj of new mutations are sampled from a
distribution of fitness effects (DFE). Just as a fixed sj would determine
properties of the sampled genotype data for a SNP, a DFE along
with mutation, recombination, and demographic parameters
induces a distribution on the observed frequency spectrum and
polymorphism - divergence ratios in sampled data. Several authors
have attempted to fit a parameterized DFE from genomic data
[25–34]. Boyko et al [33] found that a combination of a point mass
at neutrality (not under selection) combined with a gamma
distribution for deleterious differences from neutrality to be a good
fit for the DFE of non-synonymous mutations.
With these facts in mind, in what follows we will use fitness
effects to operationalize the construct of functional status for each
SNP. Whereas Johnson and Barton [23] worked directly with the
joint distribution of fitness and phenotype effects, we will use an
existing DFE estimate [33] as a marginal distribution for fitness
effects and construct the conditional distribution of phenotype
effects. Since we do not know the true fitness effects of SNPs, we
will estimate them with observed SNP frequency, which is
statistically ancillary to phenotype-SNP correlation, using a
simulation methodology described below.
Methods
Model for SNP Effects on Phenotype
Assume the context of a simple random cross-sectional sample
of n individuals (indexed by i) studying a quantitative trait Yi
measured once per individual. Assume that these individuals also
possess vectors of covariates Xi and genotypes Gi at each locus
inside a sequenced candidate gene or region. The genotypes are
coded such that ‘‘0’’ represents homozygous possession of the
ancestral allele, ‘‘1’’ heterozygosity, and ‘‘2’’ homozygous
possession of the derived allele at the locus. That is, G4,3~2
represents the fourth sampled person possessing two derived alleles
at the third locus in the sequenced region.
We can write a regression model for person i’s phenotype Yi in
terms of deviation ei from an average level predicted by covariate
effects b and additive genotype effects c,
Yi~b:Xizc:Gizei: ð1Þ
Using standard least-squares regression to estimate such a
model will pose several problems. First, because there will be many
rare variants, c will contain many poorly estimated coefficients.
Author Summary
Studies correlating genetic variation to disease and other
human traits have examined mostly common mutations,
partly because of technological restrictions. However,
recent advances have resulted in dramatically declining
costs of obtaining genomic sequence data, which provides
the opportunity to detect rare genetic variation. Existing
methods of analysis designed for an earlier era of
technology are not optimal for discovering links to rare
mutations. We take advantage of 1) the advanced
theoretical understanding of evolutionary mechanics and
2) genome-wide evidence about evolutionary forces on
the human genome to suggest a framework for under-
standing observed correlations between rare genetic
variation and modern traits. The model leads to a powerful
test for genetic association and to an improved interpre-
tation of results. We demonstrate the new method on
previously confirmed results in a gene related to high
blood cholesterol levels.
Association Testing in Resequencing Studies
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number of degrees of freedom, decreasing its power to detect
association with the candidate gene. Some of the variation
uncovered may be perfectly correlated in the sample, meaning
that those coefficients are not separately estimable in least-squares
regression. Additionally, as the amount of the genome sequenced
becomes large, there will be more variants than participants,
making the entire model unidentified.
To overcome these problems, we need to make more
assumptions and model the c coefficients. We adopt a model
where we view the effects of SNPs in the study as a sample from a
wider population of SNP effects, and characterize that entire
population using only three parameters. To fix ideas, assume for
now that we knew the fitness effect of each SNP sj. If fitness was
perfectly correlated to effect on phenotype, we would use that as a
summary for all alleles, cj~rsj, where the parameter r relates the
scales of the two measures. As the fitness effect is not perfectly
correlated to effect on phenotype, we add a mean m and an error
term g 
j acknowledging those limitations to obtain
cj~mzrsjzg 
j : ð2Þ
In applied problems, sj is not known a-priori, so we will construct a
prediction b sj sj based on the observed frequency. We denote
b sj sj:Es jDb fj fj
  
for that estimate, and for its prediction error we
write Vj:Var sj{b sj sjDb fj fj
  
. We plug those estimates in to (2) to
obtain
cj~mzrb sj sjzr sj{b sj sj
  
zg 
j , ð3Þ
and combine the two uncorrelated error terms to yield
cj~mzrb sj sjzgj, ð4Þ
where
gj~r sj{b sj sj
  
zg 
j ð5Þ
Var(gj)~r2Vjzt2w(sj): ð6Þ
The first term in (4), m, allows derived alleles to on average
increase or decrease the phenotype. The second term rb sj sj is an
unscaled correlation between phenotype effects and expected
fitness effects b sj sj. The error term gj is the deviation in SNP j’s effect
on phenotype from the average of SNPs with the same observed
frequency. The variance of gj in (6) therefore has two components,
first r2Vj corresponds to prediction error of ^ s sj, and second t2w(sj)
is the variance of phenotype effects for SNPs at the same level of
true fitness burden sj. The function w() allows that as average
burden changes the variability might also change. Although one
could imagine ‘‘bad’’ alleles being more variable in their effects
than relatively neutral alleles, implying non-constant w(),w e
propose constant w() as a reasonable modeling start. This will still
allow for the variance of effect sizes to change with observed
frequency because of non-uniformity of Vj with frequency.
Equation (4) asserts that phenotype-effect and fitness-effect are
linearly related; that seems correct for the scenario in Figure 1A
and a good starting place for the other possibilities. In future work
we will be able to empirically examine this assumption by
graphical diagnostics and comparing fits using other functional
forms. Further discussion of nonlinear relationships is found in
Text S1, and we will demonstrate the impact of an incorrect
assumption of linearity in our simulation studies.
Our model is quite general in that existing methods correspond
to submodels of (4). An allele count method tests the model with
only m allowed to vary; rare alleles below an arbitrary threshold
are summarized by an average effect which does not change with
frequency, so r and all gj are set to zero, and alleles above that
threshold are regarded as free parameters. Similarly a weighted-
burden method corresponds to the model cj~r^ s sj with a particular
implementation of ^ s sj, such as in Madsen et al [21] where
^ s sj~ ^ f f j(1{^ f f j)
   {1=2
, and forces all gj in the rare alleles to be zero.
Our model will not involve an arbitrary threshold for ‘‘rare alleles’’
and will adaptively pool variant effects in a flexible way. As shown
in the results, this will create substantial power gains in a variety of
settings.
When r and m in (4) are zero, our model reduces to a standard
random-effect model identical to that of Kwee et al [19] with all
variants given the same weight. That is, regardless of frequency all
SNPs have the same likelihood of having large effect sizes, and
regardless of frequency SNP effects have zero mean. As a result,
our method will be robust to the case that fitness and phenotype
effects are unrelated by estimating ^ r r~0 and retaining the
flexibility of the method of Kwee et al. The major difference
between the above and our method is the use of population
genetics to suggest the structure of the variance of SNP effects,
including a fallback should fitness and phenotype effect not be
related. Kwee’s method is developed in the context of tag SNPs
and suggests an arbitrary variance of SNP effects given as either a
constant, Var(cj)~t2=
ﬃﬃﬃﬃ
^ f f j
q
, or any prior-information based form.
A related method is that of Hoggart et al [18]. Their approach
Figure 1. Hypotheses relating SNP effect and fitness effect. Panel A depicts the scenario where the trait is directly under selection. Panel B
depicts the scenario where a gene with pleiotropic effects creates fitness-trait correlation via a related phenotype.
doi:10.1371/journal.pgen.1001202.g001
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distribution) and a different set of restrictions on the distribution of
g. Their assumptions about the distribution of g were chosen to
yield estimates with most variants having zero effect, a feature
called model selection which eliminates small effects and
correlated variables. In contrast, our model will tend to reign in
large effect sizes and split effect size between variants in high
linkage disequilibrium, but does not eliminate SNPs from the fit.
We prefer our choice for resequencing for several reasons. First,
there may well be many effects of small size which are
cumulatively important, and we want to retain those small effects
in the model. Second, we want an estimate of the effect size of
each variant for graphical and diagnostic purposes. Third, we
accomplish a similar goal of reducing the model size by rejecting
the null on a small number of genes. That is, we want to identify a
small number of disease relevant genes with our efficient test;
doing so will exclude most SNPs without further model selection
procedures. Fourth, by smoothly grouping rare SNPs and
summarizing them with only a few parameters, we already greatly
reduce the multiple testing burden.
Model Interpretation
The specification of equations (1), (4), and (6) yields a natural
interpretation to the fitted model. After estimating the population
parameters of phenotype effects, we will be able to jointly estimate
individual SNP effects ^ c c and their impact on the phenotype of each
person in our sample. By calculating ^ c c:Gi, we obtain the expected
difference between participant i’s phenotype and what we would
expect were there no effects of this gene. As a result we can
empirically estimate the overall phenotypic variability due to
observed genetic variants, Var ^ c c:Gi ðÞ over study participants. We
can similarly estimate the variability dues to rare alleles by
including only rare SNPs in the above calculation. The overall
effect m is an average change in phenotype per derived allele,
perhaps due to inadequate purifying selection. In the variance
expression (6), t2 is the variability of allelic effects for a given level
of true fitness. As will be shown below in Figure 2, when using the
genome-wide distribution of fitness effects for non-synonymous
SNPs, common variation is nearly neutral so t2 can also be
thought of as the variability of effects of common alleles. r
represents the correlation between fitness burden and phenotypic
burden. This parameter’s interpretation relies on accurately
estimating the scale of fitness effects and has awkward units, but
we can avoid this difficulty by noting that (4) can be decomposed
into a fitness related portion and a fitness unrelated portion which
are independent
cj~r b sj sjz sj{b sj sj
     
z g 
j zm
  
~c
fit
j zc
nf
j : ð7Þ
By calculating Var(b c c fit:Gi) we can ascribe a proportion of total
variation in phenotype to selection-phenotype correlation without
worrying about having gotten the scale of r correct. Calculations
for separating these variance components are found in Text S1.
We can use the same technique to compare classes of SNPs, for
example non-coding vs missense, by jointly fitting separate r,t,m
and comparing the attributable variance for each class of SNPs.
We will illustrate this idea in our real data example. This
decomposition also shows why it is not crucial for our estimates of
fitness to be perfect. The model can fall back by setting r to zero
and use only c
nf
j to recover a working model which does not pool
information across rare alleles. Doing so will mean that the
Figure 2. Relationship between sampled frequency and mean fitness. Simulation results using fitted DFE of non-synonymous variation from
[33] and a sample size of 1000 diploids. Red bars are median +235% of the distribution at that sampled frequency. The x-axis is logarithmic and
scaled by 100, i.e., the first point is 1/2000 chromosomes.
doi:10.1371/journal.pgen.1001202.g002
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phenotype effects will not be realized, but the remaining
estimation method is still valid.
An important consideration is how to interpret the results when
multiple ethnic groups are analyzed simultaneously. Because some
genetic variation is fixed between ethnic groups in the sample, the
average effect of single-population variation will be absorbed into
the fitted mean for that group. As a result, the interpretation for
‘‘total explained variation’’ is actually ‘‘total explained within-
ethnic-group variation;’’ genetic variation may explain some of the
phenotypic difference between groups, but we do not include it in
our estimate because of confounding between environmental
exposures and ethnic background.
Another point requiring clarification is the assumption that
genotype effects are independent. In the context of GWAS, nearby
SNPs often are thought to have correlated effects because they
mutually tag a functional variant. Additionally, estimates of SNP
effects will be correlated due to LD making their true separate
effects difficult or impossible to identify. However, in the
underlying data generating mechanism true genotype effects are
independent. Because sequencing identifies all the variation within
the region and eliminates much of the correlation due to untyped
alleles, we believe that the independence assumption is a useful
approximation in this case. Non-independence of the true effects
could be accommodated by imposing a covariance structure on
SNP effects, for example using their spatial distance in the genome
or folded protein. Alternatively, the phylogenetic approach of
TreeLD [35] estimates the degree of probable overlap of untyped
SNPs.
Computing Fitness Effects
Model (4) relies on a prediction b sj sj of the fitness effect of each
variant as well as an estimate Vj of the error of that prediction. We
use the following procedure to calculate such estimates.
1. Take as given the fitted distributional form of fitness effects and
population history since out-of-Africa [33,36].
2. Use existing software SFS_CODE [36] to simulate new
polymorphisms in the gene under study many times, creating
pseudo-samples containing true variant-level fitness.
3. For each variant in the real dataset, find variants in the pseudo-
data with the same sampled frequency, and calculate the mean
b sj sj and variance Vj of true fitness among those simulated
variants.
To reduce computational requirements, steps 2 and 3 above can
be replaced by simulating a smaller number of large populations
and calculating the expected mean and variance of fitness using
simple random sampling. Figure 2 depicts the relationship of b sj sj
and Vj to frequency when using a genome-wide fitted DFE [33].
Because much of the variation discovered in our multi-ethnic
example dataset is confined to one ethnicity, we use the ethnicity-
specific frequency and pseudo-data. Because of admixture in our
sample, we use the highest observed frequency (the most skeptical
about its being rare) to assign an ethnicity of origin to SNPs
appearing in multiple groups.
An advantage of this method is that because it refers to a feature
of genetic history rather than a phenotype, it need only be done
once for any trait under study on the same cohort. While the
fitness - phenotype relationship will be different for all traits, that is
modeled by the fitted parameter r rather than modification of ^ s s.I f
the impact of LD structure on the prediction does not vary too
much between genes, the calculation can be recycled for multiple
genes under study. In some experiments, we found the impact of
LD to be minimal (data not shown). Discussion of taking the DFE
as known versus estimating or using some other flexible function of
frequency it is included in Text S1. Discussion of the quality of the
existing DFE estimates are also included in Text S1. We have used
the observed frequency to estimate the fitness effect, but there are
many other potential predictors of functional status. Discussion of
including them in our model is found in Text S1.
Model Fitting and Estimation
Testing. Our model fitting procedure will be likelihood-based,
so we will use a standard hypothesis testing method: likelihood ratio
tests. To improve robustness, our examples will use permutation p-
values obtained by comparing the likelihood ratioof the fitted model
to that generated under the null hypothesis by randomly swapping
genotypevectorsbetweenmembersofthesameethnicity.Permuting
genotype labels simulates the null hypothesis that no relationship
exists between any genotype and any aspect of the response, which
in our parametric setup is equivalent to r~0,t~0,m~0 while
retaining the relationship between covariates (such as age and sex)
and phenotype. Because the genotypes of members of different
ethnicities are not exchangeable even under the null, we only swap
genotype vectors among individuals with the same reported
ethnicity. In admixed populations where information about local
ancestry is available, the permutation should be between individuals
with the same local ancestry.
Estimation. For numerical convenience and statistical
robustness, we will use only the first two moments of the model
in equations (1), (4), and (6), and assume w() constant in (6). This
last restriction yields a mixed-effects regression problem where the
genotype effects are crossed random factors, presented in (8) and
(9) below. A broad introduction to mixed effects regression and
many of the formulas we will use are provided in McCulloch and
Searle [37]. In matrix notation where each participant is a row
and effects are column vectors,
E½YDX,G ~XbzrG^ s szmGf1gð 8Þ
Var½YDX,G ~Is2zr2G Var s{^ s s ½  ðÞ GTzt2GGT: ð9Þ
We allow the procedure to exploit the possibility that individuals
with a high burden of rare alleles not only have drift in their mean
phenotype because of r in (8), but also more variability in
phenotype due to r in (9). Equations (8) and (9) assert that a single
parameter r regulates the change in mean variant effect and effect
variability with frequency. However, non-differential error (with
respect to phenotype) in imputing covariates biases coefficient
estimates towards the null, so if our estimations of b sj sj and Vj have
different levels of error they will experience different such biases.
As a result, we will want to fit rmean in (8) and r2
variance in (9)
separately to check that they are similar before combining them.
Because it involves an extra parameter the ‘‘split r’’ calculation
will be more variable under the null and less powerful when the
model is true. However, it may be more robust when the model is
mis-specified, as we will explore in our simulations.
We will fit the mixed effects model (8)–(9) using modified
Newton-Raphson optimization of the implied likelihood. The
linear mixed effects approach is equivalent to assuming normality
for the error terms e and g and fitting via maximum likelihood. A
major advantage of this estimation approach is that it allows for
very fast computation; the likelihood can be integrated analytically
over c when maximizing over parameters r and t. We have not
Association Testing in Resequencing Studies
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for the large example dataset. Though higher-order expansions
are possible, others have shown that most of the information is
often contained in the first two moments of the data [38,39], and
that correct specification of mean and variance models produces
correct inference robust to additional details of structure.
Assumptions which better match the data at hand will lead to
more power, but they will tend to require dramatically more
computational effort. For our current example we have considered
a single sequenced candidate gene where computational speed is
not crucial, but we expect that methods similar to ours will be
required for whole-genome or whole-exome resequencing efforts
where computational resources will be a limiting factor. Addition-
ally, popular methods such as Markov Chain Monte Carlo and
EM which can use arbitrary distributions of residuals and random
effects require accurate initial estimates to perform well; MCMC
also benefits enormously from a good proposal distribution. Mixed
effect regression is a reasonable way to generate these initializa-
tions. Whereas using only the first two moments for estimation is
only optimal under the normality of YDX,G, it will still yield
consistent estimates if normality does not hold, and we can use use
robust methods of testing the null hypothesis such as permutation
p-values. This quasi-likelihood-based method also yields best linear
unbiased estimates for the SNP phenotype effects [37, chapter 6],
which we relied upon in ‘‘model interpretation’’.
Implementation. As discussed above, we will be interested in
fitting distinct rmean in (8) and r2
variance in (9) because of concerns
about different magnitudes of error in the computation of ^ s sj and
Vj. In such a scenario, we can use the SAS MIXED procedure [40]
to estimate the model parameters and check our custom software.
Example code implementing this use is maintained at the authors’
website. We generate confidence intervals using the standard
asymptotic arguments in McCulloch and Searle [37, chapter 6],
which are built into SAS.
Alternatively, if we use a single r in the mean and variance
models, the result is a model which is not easily fit in any standard
statistics package of which the authors are aware. We have created
a set of functions in the R programing language [41] to estimate
this model using optim to maximize the likelihood, code for which
is posted at the authors’ web site: http://home.uchicago.edu/
,crk8e/papersup.html
Bayesian interpretation. Our model is easily recast in a
purely Bayesian framework. One would need to write priors for
r,t,m and the effects of covariates. The frequentist formulation is
just the Bayesian formulation with an improper uniform prior
distribution on the variance components. As a result, using
Bayesian regression software like R’s MCMCglmm package or
winBUGs is an alternative for estimation. A reasonable way to
generate proper informative priors would be a three step
calculation. First, estimate a posterior distribution on variance
explained by genetic factors from previous linkage studies. Because
many phenotypes may not have available linkage studies or very
low resolution, one may have to rely on other phenotypes or
animal model results. Second, equate the resulting prior on
attributable variance to the expression in Text S1 with observed
values for the genotype data. Third, assign an arbitrary fraction of
the explained variation to each source and back-calculate to find
the square of the parameter.
The Bayesian analyst could continue to use our normal
approximation of the distribution of the latent sjD^ f fj which allows
it to be integrated out, or could model it directly including the
point mass at zero and skew distribution from the simulation
result. The result would be a large model with many latent
variables, some of which are poorly identified.
Results/Discussion
Dallas Heart Study: ANGPTL4
Description of dataset. About 3500 prospectively sampled
individuals from the population in Dallas, Texas, were sequenced
at a candidate gene for dyslipidemia: ANGPTL4 (Ensembl
Acc:16039). These individuals come primarily from three ethnic
backgrounds: non-Hispanic white (N=1043), non-Hispanic black
(N=1832), and Hispanic (N=601). We will exclude from our
analysis the 75 individuals listed as ‘‘Other’’ ethnicity. Our outcome
phenotype is log-transformed serum triglyceride levels. Details of the
cohort [42], its metabolic phenotypes [43], and the sequencing
methods and discovered genetic variation [8,12] have been de-
scribed previously. We grouped all missense and nonsense mutations
into a single category which we label ‘‘non-synonymous’’ in the
tables and figures, and we grouped all synonymous and non-
coding region mutations into a single category labeled ‘‘non-
coding.’’ Table 1 shows the number of discovered SNPs in each
category in each ethnic group. We consider age, sex, ethnicity,
diabetes status, and self-reported ethanol consumption as adjuster
covariates. For age, we use a flexible linear spline model with knots
at every ten years to allow for nonlinearity in response. We include
all interactions between ethnicity and gender and ethnicity-gender
interactions with other covariates. Because statin use is an
endogenous variable indicating diagnosed dyslipidemia, we do
not adjust for it. We fit models 1) ignoring statin use and 2)
increasing triglyceride levels 25% in the treated to approximate
their untreated level. Because we obtained qualitatively similar
results, we present only the latter.
Model estimates. Table 2 presents model summaries and
point estimates with asymptotic standard errors for model
parameters, stratified by ethnicity and pooled using ethnicity as
an adjuster. Table 2 presents the results setting the offset term m to
zero. We found that including m in (4) produced poor fits when
there were few variants, for example when using only the Hispanic
non-synonymous variants (n=8). In the pooled estimate, including
the offset did not qualitatively change the result.
For ANGPTL4, we observe a p-value of .006 on 10,000
permutations versus the strong null hypothesis that no SNPs have
any effect. Previous authors [12] observed a p-value for a net
surplus of non-synonymous variants in low triglyceride partici-
pants of .016 and a minimum variant-at-a-time p-value of .019 for
E40K corrected for multiple testing. The improvement to the
model fit by including r is small in this case; a likelihood-ratio p-
value using the asymptotic distribution is non-significant. As seen
in Table 2, a glimmer of a fitness component is only seen in the
non-coding variation, and the explained variance is very small.
However, to illustrate the interpretation of the plots which our
approach generates we’ll take the parameter estimates at face
value below.
Table 1. Genetic variation in ANGPTL4.
Population N individuals
N Non-synonymous
variants
N Non-coding
variants
Pooled 3476 32 62
Non-Hispanic
whites
1043 20 23
Non-Hispanic
blacks
1832 15 38
Hispanic 601 8 17
doi:10.1371/journal.pgen.1001202.t001
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observed SNPs and estimated effect sizes (non-synonymous in
black and non-coding in red) rank ordered by observed frequency
(in blue). Variant-at-a-time ordinary least squares (OLS) estimates
of effect size are overlaid in green. Figure 3 displays several
interesting features of the data; first there are two low-frequency
non-synonymous variants with a strong effect reducing triglyceride
levels; the first is E40K (frequency in non-Hispanic whites=.012,
frequency in non-Hispanic blacks=.003), the sole variant
identified by Romeo et al [12]. However, adjusted for E40K we
see that another more common variant R278Q almost exclusive to
non-Hispanic blacks (frequency=.055) also appears to decrease
triglyceride levels. We observe a weak tendency for all non-
synonymous variation to reduce the phenotype; Romeo [12] also
noted an excess of rare non-synonymous variants in those with low
triglyceride levels. The rare non-coding variation appears to have
the opposite sign of effect; it increases triglyceride levels. Referring
to Table 2 we see that a fitness-related component of variability (of
about the same scale as the change in mean) was detected; this
gives rise to the wider spread of point estimates and wider
confidence intervals in non-coding variation.
An interesting data point in Figure 3 is a single 5% frequency
non-coding variant (directly before R278Q) whose OLS effect
estimate is quite large (and nominally significant) but whose
model-based effect estimate is small. Examining that variant more
closely, we found that it is in strong LD with R278Q. Because
E40K (which is not strongly correlated to any other variation) had
a large effect and non-synonymous variants tended to decrease
triglycerides, the model assigned non-synonymous variation as
more likely to have non-rare variation with large negative effect
sizes and gives the effect to R278Q. Similarly, perfectly correlated
rare variants have their combined effect split evenly.
We can understand this model fit by looking at the green OLS
estimates in Figure 3. Visually, the estimates for non-synonymous
variation tend to be below zero. Comparing the non-synonymous
to non-coding singletons, we see more variable estimates in the
non-coding singletons as well as a different mean. The model fit
identifies this as opposite signs of rmean and a much greater r2 in
non-coding. The non-rare non-synonymous variants with large
effects (E40K, R278Q) drive the larger estimate of t2 versus non-
coding variants; examining Figure 2 we see that common variation
is essentially neutral with respect to fitness, and as a result non-zero
effects in non-rare variants force t2 away from zero.
Evolutionary interpretation. An interesting potential story
about natural selection on ANGPTL4 activity emerges from
Figure 3. First, non-synonymous mutation tended to decrease the
effectiveness of ANGPTL4 and decrease serum triglyceride levels
[8,44,45]. We see no evidence of selection against those mutations;
variants which decreased triglycerides became more than rare in
both the African and European lineages, and we see no excess of
large effects in rare SNPs. On the other hand, non-coding
mutations which may alter the regulation of ANGPTL4 on
average increased triglycerides. Variants with large effect sizes
were preferentially rare, and the apparent selective force was
stronger in the non-European lineage, as the demographic history
would predict. This meshes well with the finding that ANGPTL4
experienced a Europe specific relaxation of purifying selection
[12]. We do not suggest that serum triglyceride levels in themselves
were the target of purifying selection; effect on triglycerides may
only be correlated to effect on a selected function.
Simulation Studies
Population parameters. In order to determine the power
and robustness of our procedure, we simulated variation in a gene
with the exon structure of the gene ANGPTL4 in a study
population using SFS_CODE [36] and fitted demographic and
DFE parameters [31,33]. We used 4cM/mb for the local
recombination rate and no recombination hotspots. We used
1:8=108 as the mutation rate per-nucleotide-per-generation. From
the final simulated population of about 20,000 individuals we
sampled 1000 individuals independently for each of 1000
simulation runs. SFS_CODE commands creating the simulated
population are available at the authors’ web site. We created
simulated phenotypes according to (1) and (2) using parameters
described below. The total simulated population had 132 coding-
region SNPs, 29 of which were at frequency greater than 1%.
Model parameters. We chose several levels of the
phenotype parameters to correspond to potential cases of
interest while keeping the total fraction of variation explained by
the gene about the same: a weak mean variant effect, a strong
fitness-related component of the phenotype, and a strong fitness
independent component of the phenotype. We chose the baseline
values such that r and t explain about the same amount of
variation in phenotype. We also created a scenario with no fitness-
phenotype correlation whatsoever. To ensure that type 1 error
rates were correct, we include a simulation under the null
hypothesis that no variants have any effect on phenotype. Table 3
contains the chosen phenotype parameter values for each set of
simulations and the resulting expected percent of variance
Table 2. Model fit for ANGPTL4.
Population SNP Type ^ t t D^ r rvarianceD ^ r rmean SE
nonfitness %
variance
fitness %
variance
Pooled non-syn 0.13 0.0 2.5 8.7 0.54 0.003
Pooled non-coding 0.02 8.3 29.6 6.5 0.09 0.08
NHW non-syn 0.15 0.0 5.8 13.5 0.53 0.03
NHW non-coding 0.02 0.0 1.9 7.3 0.004 0.008
NHB non-syn 0.08 0.0 0.5 11.4 0.42 0.0002
NHB non-coding 0.02 0.0 211.4 8.1 0.07 0.13
Hispanic non-syn 0.00 0.0 20.5 43.9 0 0.03
Hispanic non-coding 0.10 19.6 240.8 38.2 0.08 0.66
Parameters are defined in equations (1), (4), and (6). SE is for rmean. Attributable variance is that due to decomposition (7), see Text S1 for calculation. Pooled model
p=.0064 on 10000 permutations. Pooled model residual variance=0.29. NHW is non-Hispanic white; NHB is non-Hispanic black.
doi:10.1371/journal.pgen.1001202.t002
Association Testing in Resequencing Studies
PLoS Genetics | www.plosgenetics.org 7 November 2010 | Volume 6 | Issue 11 | e1001202explained by the SNPs due to fitness-phenotype correlation and
percent of variance explained independent of that correlation.
Two additional batches of simulation examine the robustness of
our procedure to incorrect assumptions. First we created violations
of the assumed population model. We mis-specified the assumed
DFE in our analysis, making the scale parameter a factor of 5 too
large or too small and keeping the truth the same. We also
simulated violation of our demographic assumptions using a
population which experienced an additional 100 fold exponential
growth over the last 11% of generations since out-of-Africa.
Second we created violations of the assumed statistical model. We
simulated three scenarios violating the linearity assumption. First,
with cj proportional to s2
j , second proportional to ﬃﬃﬃﬃ sj
p , and third a
50/50 mixture of sj and {sj. We simulated g 
j using a highly
skewed log-normal distribution which was then standardized to
have mean zero and variance t2. We also simulated with 20% and
80% of the variants having an effect size of zero.
Power comparisons. To compare power with existing
methods, we included several proposed methods of analysis.
First, we test the method of Bonferroni corrected minimum p-
value of SNPs with minor allele frequency .1% or .5%. Other
proposed methods using allele counts like CAST [46] CMC [20]
and weighted sums [21] were created for case-control studies, so
we alter those methods to be fair in a cohort quantitative-trait
context. Our representative of CAST-like analysis is regression
with the number of rare variants carried by each participant as a
Figure 3. Frequency versus estimated effect size in ANGPTL4 with ordinary least squares estimates. The SNPs have been rank-ordered
by observed frequency on the x-axis with ties broken by estimated effect size. The left y-axis is the predicted effect (^ c cj in (4) ) on the log of serum
triglycerides. Green solid dots are the point estimate for each variant’s effect on log-triglycerides from one variant at a time ordinary least squares
adjusted for non-genetic covariates. Open circles are joint point estimates of ^ c c from our method, and bars 95% prediction intervals on those
estimates. Confidence intervals are the elementwise Wald-type estimates described in chapter 6 of [37] and produced by SAS’s estimate command in
the mixed procedure. See Text S1 for the calculation of point estimates, and the sample code at the author’s website for SAS commands. Non-
synonymous variation is in black; non-coding variation in red. The right y-axis and blue line depict observed count pooled across ethnicities on a log
scale.
doi:10.1371/journal.pgen.1001202.g003
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(frequency greater then 1% or 5%) treated as free regression
parameters. P-values are then generated by ANOVA against the
nested model consisting only of only fitting the mean response.
Our representative of weighted-sum type methods is a similar
regression analysis where rare variants are collapsed to a mean
model with burden proportional to ^ f f j(1{^ f f j)
   {1=2
, which is the
same weight used by Madsen et al [21]. Because the simulated
response is actually normal, we do not use a rank transformation.
We also used the same burden function for only low frequency
SNPs and treated common SNPs as regression parameters. P-
values are again obtained by ANOVA versus a nested model with
no genetic effects.
To demonstrate the gain (or loss) in information by considering
the marginal variance, we apply a similar regression with an
optimal mean model, that is (8) either for all SNPs or treating
common SNPs as free. We tested our model both with a single r in
the mean and variance and the ‘‘split r’’ calculation where
separate parameters are fit in (8) and (9).
Table 4 summarizes the power comparisons in each case. Our
model is as or more powerful than the existing methods, even
when there is substantial violation of its assumptions. The only
scenario in which our model loses some power is when there is
absolutely no fitness-phenotype correlation. Even in that case, the
relative loss is small, much smaller than the gain when r was not
zero. The additional utility of the method varies substantially
depending on the chosen parameters. For example, when the
fitness-phenotype correlation accounts for about half the genetic
component of the phenotype (the basic scenario), our method
provides a substantial improvement, but when t is large (common
variants have large effect sizes) the benefit is less. Our model
appears reasonably robust to all the violations of assumptions
which we tested, even providing a performance benefit when effect
sizes were very skew or the true relationship was nonlinear. In
effect, the truth in those cases lined up less well with the implicit
assumptions of the competing methods. Perhaps most importantly,
even fairly substantial mistakes in the DFE and demographic
history did not dramatically reduce the power of our method. The
‘‘split r’’ model appears to perform about the same as a single r.
The minimum p-value method’s poor showing in some scenarios is
explained by the data generating mechanism we chose; when t is
small or many SNPs have zero effect there will often be no
common variants with appreciable effect sizes.
Discussion
We propose a novel method, EMMPAT, for association
between sequenced genes and phenotype which utilizes population
genetic theory to pool information among rare variants. Our
method generalizes allele-count and allele-burden techniques, and
presents several advantages. Of greatest importance to the
practicing scientist will be increased power and interpretability.
As shown above, our method allows us to leverage allele frequency
as auxiliary data related to SNP effects and to substantially
increase power to detect association in many scenarios. The
availability of a well motivated pooling strategy allows an omnibus
test which incorporates common and rare variation simultaneous-
ly. Our approach provides clear interpretations for the fitted
model, such as the attributable variance in phenotype due to all
polymorphisms observed in a gene, particular types of SNPs, or
only the rare variation. Furthermore it facilitates tests of
meaningful parameters (such as mean derived allele burden) and
group differences (such as non-synonymous versus non-coding).
The regression toolbox allows model checking and exploration,
such as in Figure 3 which presents the data in an informative
format. Additional model checking proceeds as usual in linear
mixed models, and posterior predictive checks are similarly
possible.
A relevant question is how important our method will be for
diseases which have not been strongly selected against. There are
three answers to consider. First, when selection and disease effect
are completely independent, common SNPs will tend to have just
as large effect sizes as rare SNPs and explain much of the heritable
variation in phenotype [2,3]. We believe that most investigators
conducting resequencing studies assume rare variation to have
larger effect sizes, since that is the best-justified scenario for the
expense of sequencing. Second, our method allows for this
possibility in the form of estimating r to be zero and t non-zero.
As demonstrated in our simulations, the loss of power in adding a
single unnecessary parameter to describe many SNPs is small.
Third, as discussed in the Introduction and Text S1, direct
selection against disease is not a necessary condition for correlation
between fitness and phenotype; as long as the disease related gene
is under selective pressure in any of its functions, we expect a
correlation.
We have planned several extensions to this method. In addition to
improved techniques of estimating fitness effects, we need to
incorporate evidence for adaptive selection. Signatures of positive
selection [47–49] can beusedtoprioritizegenes for studywhich may
have been more important in differentiating humans from our
ancestors and hence contribute to modern phenotypes. We expect
positively selected variants to have very different phenotype effects
from neutral alleles, but it is not clear a-priori what that relationship
should be or if it will be possible to reliably identify positively selected
SNPs[50,51].Second, for mathematical and numericalconvenience
Table 3. Simulation design.
scenario rtm
residual standard
deviation
expected fitness %
variance explained
expected nonfitness %
variance explained
Base 27.0 0.012 0.007 0.22 0.84 0.84
High r 221.0 0.012 0.007 0.50 1.51 0.17
High t 27.0 0.018 0.007 0.28 0.55 1.13
Low m 26.4 0.012 0.003 0.21 0.83 0.85
Very high r 263.1 0.012 0.003 1.43 1.66 0.02
Zero r 0.0 0.012 0.007 0.16 0.00 1.68
Parameters chosen for simulation. Data generated by mechanism of formula (1) and (2). Parameters defined in equations (1), (2), and (6). Explained variance is the
average true variance over individuals of fitness component and fitness independent component.
doi:10.1371/journal.pgen.1001202.t003
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probability sample measuring a quantitative trait. Both these
assumptions need to be relaxed for the setting of most resequencing
projects. Disease phenotypes are frequently non-normal, binary, or
censored such as time-to-event from clinical trials, requiring a
generalized linear mixed model. The prospective sampling assump-
tion willalsorequire worktorelax.Retrospective sampling suchas in
case-control designsand extreme-phenotype-based sampling [13,52]
is well known to distort random effect distributions [53]. Third, in
our example and simulations, we assume that gj are independent of
one another, but one need not do this. One could add spatial
covariance structures between gj to relax the independence
assumption, which would correspond to allowing that variants
nearby each other in the genome or folded protein tend to have
similar effects. Especially in exome-only resequencing studies,
consideration of unobserved linked markers with techniques similar
to TreeLD [35] will be important. Our model has not included
dominance or epistasis between SNPs or genes, the structure of
which is probably not simple, although progress has been made on
determining the impact of these features to quantitative traits
[54,55]. Finally, because our example dataset comes from high-
quality Sanger sequencing, we have ignored nonrandom missing
data issues. Future work involving second generation sequencing
or beyond must address the complex nature of library cover-
age, alignment error, and genotyping error inherent in those
technologies.
Supporting Information
Text S1 Supplementary methods and discussion.
Found at: doi:10.1371/journal.pgen.1001202.s001 (0.05 MB PDF)
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